| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
CCSI
Consensus Cloud Solutions
|
Jul 24, 2026 | BUY |
Buy
-16.6% avg upside
6 analysts
|
$45.00
22.61% Upside
|
· | · |
|
LFST
Lifestance Health Group
|
Jul 24, 2026 | BUY |
Strong Buy
+0.8% avg upside
15 analysts
|
$15.00
38.17% Upside
|
-2.0% | · |
|
PGNY
Progyny
|
Jul 24, 2026 | BUY |
Strong Buy
+4.6% avg upside
14 analysts
|
$40.00
27.42% Upside
|
-2.6% | · |
|
HQY
Healthequity
|
Jul 24, 2026 | BUY |
Strong Buy
+10.4% avg upside
20 analysts
|
$115.00
10.45% Upside
|
+10.0% | · |
|
CYRX
CryoPort
|
Jul 24, 2026 | BUY |
Strong Buy
+0.1% avg upside
15 analysts
|
$25.00
67.48% Upside
|
+0.0% | · |
|
OMDA
Omada Health, Inc.
|
Jul 17, 2026 | BUY |
Strong Buy
+25.8% avg upside
12 analysts
|
$30.00
53.01% Upside
|
-13.4% | · |
|
EVH
Evolent Health
|
Jul 16, 2026 | BUY |
Strong Buy
+200.3% avg upside
19 analysts
|
$8.00
142.33% Upside
|
-41.8% | · |
|
ASTH
Astrana Health
|
Jul 16, 2026 | BUY |
Strong Buy
+54.3% avg upside
16 analysts
|
$65.00
78.00% Upside
|
-9.1% | · |
|
TOI
Oncology Institute
|
Jul 15, 2026 | BUY |
Strong Buy
+32.6% avg upside
7 analysts
|
$9.00
88.62% Upside
|
-14.8% | · |
|
BTSG
BrightSpring Health Services, Inc.
|
Jul 06, 2026 | BUY |
Strong Buy
-5.2% avg upside
20 analysts
|
$90.00
29.75% Upside
|
+3.0% | · |
|
SLP
Simulations Plus
|
Jun 16, 2026 | HOLD |
Buy
+106.8% avg upside
11 analysts
|
$18.50
0.95% Upside
|
+0.5% | · |
|
HSIC
Henry Schein
|
Jun 11, 2026 | BUY |
Buy
+1.7% avg upside
25 analysts
|
$100.00
16.41% Upside
|
+6.0% | · |
|
MDLN
Medline
|
Jun 09, 2026 | BUY |
Strong Buy
+26.1% avg upside
26 analysts
|
$55.00
37.18% Upside
|
+11.3% | · |
|
VEEV
Veeva Systems
|
Jun 03, 2026 | BUY |
Strong Buy
+15.2% avg upside
37 analysts
|
$340.00
63.54% Upside
|
+11.8% | · |
|
DOCS
Doximity
|
May 14, 2026 | HOLD |
Buy
+52.2% avg upside
28 analysts
|
— | +13.6% | · |
|
DCGO
DocGo
|
May 12, 2026 | HOLD |
Buy
+316.4% avg upside
7 analysts
|
— | +5.0% | · |
|
HCAT
Health Catalyst
|
May 12, 2026 | HOLD |
Buy
+161.6% avg upside
15 analysts
|
— | +35.8% | · |
|
DH
Definitive Healthcare Corp
|
May 11, 2026 | HOLD |
Hold
+665.7% avg upside
19 analysts
|
— | -30.6% | · |
|
LFMD
LifeMD
|
May 07, 2026 | BUY |
Strong Buy
+215.6% avg upside
14 analysts
|
$10.00
174.63% Upside
|
-13.8% | · |
|
AMWL
American Well
|
May 05, 2026 | HOLD |
Hold
+33.0% avg upside
15 analysts
|
— | +69.3% | · |
|
TDOC
Teladoc
|
Apr 30, 2026 | HOLD |
Buy
+230.6% avg upside
37 analysts
|
— | +42.9% | · |
|
OMCL
Omnicell
|
Apr 28, 2026 | HOLD |
Strong Buy
+31.7% avg upside
12 analysts
|
— | -12.4% | · |
|
HIMS
Hims & Hers Health
|
Mar 05, 2026 | HOLD |
Buy
+4.0% avg upside
22 analysts
|
— | +57.4% | · |
|
IQV
IQVIA Holdings
|
Feb 05, 2026 | HOLD |
Strong Buy
-2.7% avg upside
39 analysts
|
— | +30.8% | · |
|
PIII
P3 Health Partners
|
Nov 14, 2025 | HOLD |
Buy
+1815.5% avg upside
8 analysts
|
— | +36.1% | · |
|
AGL
Agilon Health
|
Nov 04, 2025 | HOLD |
Buy
-46.0% avg upside
26 analysts
|
— | +411.9% | · |
|
PRVA
Privia Health Group
|
Mar 05, 2025 | BUY |
Strong Buy
+31.4% avg upside
26 analysts
|
$35.00
45.18% Upside
|
-7.2% | · |
|
BBLNF
Babylon Holdings
|
Jun 23, 2023 | HOLD |
Buy
+65549900.0% avg upside
6 analysts
|
— | · | · |
|
CRL
Charles River Labs
|
Aug 14, 2019 | HOLD |
Strong Buy
-10.2% avg upside
34 analysts
|
— | +69.5% | · |
|
CVS
CVS Health
|
Aug 14, 2019 | HOLD |
Strong Buy
-1.5% avg upside
39 analysts
|
— | +15.6% | · |
|
COR
Cencora
|
Aug 14, 2019 | HOLD |
Buy
-1.5% avg upside
43 analysts
|
— | +30.1% | · |
|
CAH
Cardinal Health
|
Nov 16, 2018 | HOLD |
Buy
-13.8% avg upside
29 analysts
|
$55.00
76.04% Downside
|
+5.7% | · |
|
ACH
Accendra Health
|
Oct 31, 2018 | HOLD |
Hold
+427.0% avg upside
17 analysts
|
$9.00
171.12% Upside
|
-13.7% | · |
|
MCK
McKesson
|
May 29, 2018 | HOLD |
Strong Buy
-16.9% avg upside
27 analysts
|
$160.00
81.96% Downside
|
-10.2% | · |
|
MDRX
Veradigm
|
Jun 19, 2017 | HOLD |
Buy
+195.2% avg upside
22 analysts
|
$13.00
159.97% Upside
|
+2.7% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.